Treatment Subject | Plasma Vismodegib | Plasma Total Radioactivity | AUC0-inf Ratioa | ||||
---|---|---|---|---|---|---|---|
Cmax | AUC0-inf | t1/2 | Cmax | AUC0-inf | t1/2 | ||
μM | μM · h | h | μM-equiv | μM-equiv · h | h | ||
S0007 | 8.12 | 1940 | 157 | 8.81 | 2210 | 190 | 0.878 |
S0008 | 9.49 | 4180 | 269 | 11.5 | 4230 | 278 | 0.988 |
S0009 | 7.31 | 4510 | 329 | 13.1 | 7080 | 291 | 0.637 |
S0010 | 6.08 | 2540 | 277 | 7.00 | 2830 | 262 | 0.898 |
S0011 | 7.56 | 2040 | 182 | 12.1 | 3040 | 194 | 0.671 |
S0012 | 7.50 | 1550 | 128 | 16.9 | 3310 | 149 | 0.468 |
Mean | 7.67 | 2790 | 224 | 11.6 | 3780 | 227 | 0.757 |
S.D. | 1.12 | 1250 | 79.2 | 3.47 | 1750 | 57.5 | 0.197 |
↵a AUC0-inf ratio is equal to plasma vismodegib AUC0-inf/plasma total radioactivity AUC0-inf.